# John Oyler

> John Victor Oyler is an American entrepreneur and the co-founder, chairman and CEO of BeOne Medicines, established with Xiaodong Wang in 2010 as BeiGene. A Pittsburgh native trained in mechanical engineering at MIT and business at Stanford, he previously worked at McKinsey and held leadership roles at Genta, Telephia, Galenea and BioDuro. His public accounts emphasize practical operations, distributed decision-making, mentorship and building an enduring global company.

- **Role:** Co-Founder, Chairman and Chief Executive Officer at BeOne Medicines
- **Organizations:** BeOne Medicines (formerly BeiGene), BioDuro, Galenea, Telephia, Genta, McKinsey & Company, Stanford Graduate School of Business Advisory Council, Biotechnology Innovation Organization (former board member)
- **From:** Pittsburgh, United States
- **Nationality:** American
- **Education:** B.S. in Mechanical Engineering, Massachusetts Institute of Technology, MBA, Stanford Graduate School of Business
- **Known for:** Co-founded BeOne Medicines and has led the company since its 2010 inception., Named a 2025 EY Entrepreneur Of The Year US category winner., Named a 2025 EY Entrepreneur Of The Year New England winner.

## Career timeline

- **1990** — Completed his MIT degree and began his professional career at McKinsey & Company.
- **1996** — Earned an MBA from Stanford University.
- **1997–1998** — Served as co-CEO of Genta.
- **1998–2002** — Founder and president of Telephia; Nielsen later acquired the company in 2007.
- **2002–2004** — CEO of Galenea.
- **2005–2009** — President and CEO of BioDuro, subsequently acquired by PPD.
- **2010** — Co-founded BeiGene with Xiaodong Wang; began serving as CEO and leading its board.
- **2016** — BeiGene listed on Nasdaq.
- **2018** — BeiGene listed in Hong Kong.
- **2021** — BeiGene listed on the Shanghai STAR Market.
- **2024** — Attended the July opening of the company’s $800 million Hopewell, New Jersey campus.
- **2025** — BeiGene became BeOne Medicines; the name change and Swiss redomiciliation took effect May 27.

## Achievements

- Co-founded BeOne Medicines and has led the company since its 2010 inception.
- Named a 2025 EY Entrepreneur Of The Year US category winner.
- Named a 2025 EY Entrepreneur Of The Year New England winner.
- Led a company that reported approximately 12,000 employees across six continents in its 2025 history milestones.
- Founded and served as president of Telephia before its later acquisition by Nielsen.

## Latest updates

- **2026-08** — BeOne reported second-quarter total global revenue of $1.7 billion, 30% above the prior-year quarter, and raised its full-year revenue guidance to $6.6–$6.8 billion; Oyler remained co-founder, chairman and CEO.
- **2026-01** — Featured in Morgan Stanley’s Exceptional Leaders / Exceptional Ideas interview series on January 12.
- **2025-06** — Named an EY Entrepreneur Of The Year 2025 New England award winner.
- **2025-05** — The company’s name change to BeOne Medicines and redomiciliation to Switzerland became effective May 27.

## Links

- Website: https://beonemedicines.com
- LinkedIn: https://www.linkedin.com/in/john-v-oyler
- Twitter/X: https://x.com/johnvoyler

---

Profile page: https://yespress.io/john-oyler
Published by YesPress — https://yespress.io
Last updated: 2026-10-21